Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
Annovis Bio
ANVS
$76.1M
| $1.3M | ﹤0.01% |
40,945
+2,376
| +6% | +$137K |
|
3552
Lee Enterprises
LEE
$181M
| $1.3M | ﹤0.01% |
57,315
-246
| -0.4% | -$6.24K |
|
3553
Quad
QUAD
$506M
| $1.29M | ﹤0.01% |
304,913
+39,827
| +15% | +$164K |
|
|
DMK
3554
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $1.29M | ﹤0.01% |
19,056
+683
| +4% | +$50K |
|
|
OPNT
3555
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
| $1.29M | ﹤0.01% |
50,244
+37,362
| +290% | +$668K |
|
3556
Eastern Company
EML
$154M
| $1.29M | ﹤0.01% |
51,216
+3,286
| +7% | +$91.8K |
|
|
SRGA
3557
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $1.28M | ﹤0.01% |
39,198
+7,956
| +25% | +$291K |
|
|
CLVR
3558
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
| $1.28M | ﹤0.01% |
5,494
-25
| -0.5% | -$7.08K |
|
|
HZN
3559
DELISTED
Horizon Global Corporation
HZN
| $1.28M | ﹤0.01% |
181,515
+2,350
| +1% | +$19K |
|
3560
Laird Superfood
LSF
$48.2M
| $1.27M | ﹤0.01% |
66,853
-7,636
| -10% | -$175K |
|
|
WBK
3561
DELISTED
Westpac Banking Corporation
WBK
| $1.27M | ﹤0.01% |
68,709
+3,654
| +6% | +$68.2K |
|
3562
Amtech Systems
ASYS
$280M
| $1.27M | ﹤0.01% |
111,067
+967
| +0.9% | +$9.9K |
|
|
LEVL
3563
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
| $1.27M | ﹤0.01% |
43,144
+1,497
| +4% | +$41.3K |
|
|
XELA
3564
DELISTED
Exela Technologies, Inc. Common Stock
XELA
| $1.26M | ﹤0.01% |
163
+86
| +112% | +$881K |
|
3565
Intellicheck
IDN
$75.9M
| $1.26M | ﹤0.01% |
154,004
+5,768
| +4% | +$49K |
|
3566
Anixa Biosciences
ANIX
$109M
| $1.26M | ﹤0.01% |
263,951
+50,147
| +23% | +$226K |
|
3567
Summit Therapeutics
SMMT
$11.2B
| $1.26M | ﹤0.01% |
251,486
+29,893
| +13% | +$215K |
|
|
ELOX
3568
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
| $1.26M | ﹤0.01% |
19,321
+6,138
| +47% | +$378K |
|
3569
Westwood Holdings Group
WHG
$184M
| $1.26M | ﹤0.01% |
66,177
+1,941
| +3% | +$42.1K |
|
3570
STMicroelectronics
STM
$48.1B
| $1.25M | ﹤0.01% |
28,704
+686
| +2% | +$28.9K |
|
3571
Vera Therapeutics
VERA
$2.08B
| $1.24M | ﹤0.01% |
71,608
+55,532
| +345% | +$993K |
|
3572
Biodesix
BDSX
$251M
| $1.24M | ﹤0.01% |
7,551
+253
| +3% | +$48K |
|
3573
Vaalco Energy
EGY
$592M
| $1.24M | ﹤0.01% |
421,598
| – | – |
|
3574
Silvercrest Asset Management
SAMG
$79.5M
| $1.24M | ﹤0.01% |
79,343
+6,152
| +8% | +$96.9K |
|
3575
Meridian
MRBK
$240M
| $1.23M | ﹤0.01% |
86,100
+708
| +0.8% | +$9.6K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.